14 March 2023

Booklet based on new EUPROMS results will help patients weigh treatment choices

The combined results of Europa Uomo’s EUPROMS 1.0 and EUPROMS 2.0 studies are now available for men with prostate cancer and their clinicians to download, in the form of an easy-to-understand booklet.

Europa Uomo hopes that the booklet, providing EUPROMS evidence about the real experiences of men after treatment for prostate cancer, will be used by patients and urologists as they weigh decisions about best treatment together. It was launched at the European Association of Urology (EAU) Congress in Milan, where it was available from the Europa Uomo booth (pictured).

The EUPROMS studies, conducted in 2019 and 2022, have provided for the first time patient data from outside the clinic indicating how prostate cancer treatment has subsequently affected their quality of life. The new combined findings show that:

  • Those who had received prostatectomy and radiotherapy both experienced a significant reduction in sexual function related quality of life – with scores three times lower than those on active surveillance
  • 20% of men had good erections after prostatectomy or radiotherapy treatment, compared with 58% on active surveillance
  • 47% of men treated with prostatectomy had to use at least one incontinence pad a day after treatment.

“The findings presented in the booklet provide information that may help patients and their doctors make decisions about treatments, and also help in campaigning for early diagnosis of prostate cancer and promoting approaches such as active surveillance,” said Europa Uomo’s André Deschamps, who co-authored the booklet.

Quality of life after prostate cancer treatment: what Europa Uomo's EUPROMS research found out is available for download here.